Pfizer

Running trials

• Active, not recruiting

  Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations

  NCT07906262· Source

• Active, not recruiting

  A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide Among Men With Metastatic Castration Sensitive Prostate Cancer (mCSPC)

  NCT07779590· Source

• Active, not recruiting

  A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment

  NCT07567352· Source

• Recruiting

  A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

  NCT05721937· Source

• Active, not recruiting

  Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

  NCT05198245· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

  NCT06961331· Source

• Completed

  A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Japanese Market

  NCT07096024· Source

• Completed

  Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey

  NCT06680206· Source

• Completed

  A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care Therapies

  NCT06592222· Source

• Completed

  A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.

  NCT06467370· Source

• Completed

  Description of Relugolix Use in Patients With Prostate Cancer Within the VHA

  NCT06462014· Source

• Completed

  Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy

  NCT06393465· Source

• Completed

  A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.

  NCT06532357· Source

• Completed

  A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis

  NCT06418529· Source

• Completed

  Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

  NCT06412965· Source

• Terminated

  Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

  NCT05876377· Source

• Completed

  A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

  NCT06504524· Source

• Completed

  A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).

  NCT06029452· Source

• Completed

  A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings

  NCT05954546· Source

• Completed

  A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV

  NCT05794191· Source